Feature electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines By Len Zehr With FDA approval in hand for its gammaCore Sapphire therapy for the acute treatment of episodic cluster headaches and migraines, electroCore (NASDAQ:ECOR) is now focused on commercialization and... September 25, 2018